DexCom vs Koninklijke Philips
DexCom (DXCM), health care, and Koninklijke Philips (PHG), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
DexCom is worth $30.6B on the stock market and Koninklijke Philips $29.2B: DexCom is valued at 5% more. DexCom trades at 32.3 times earnings and Koninklijke Philips at 26.0; operating margins in their latest fiscal years were 19.6% and 7.98%. Over the past year DexCom's share price has moved +35.6% and Koninklijke Philips's +9.64%.
Key facts
- DexCom market value
- $30.6B
- Koninklijke Philips market value
- $29.2B
- DexCom P/E
- 32.3
- Koninklijke Philips P/E
- 26.0
- DexCom revenue
- $4.7BFY to 2025-12-31
- Koninklijke Philips revenue
- $19.8BFY to 2025-12-31
- Superinvestors holding both
- 0
Market values as of .
| Measure | DexCom | Koninklijke Philips |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $30.6Bhigher | $29.2Blower |
| Revenue | $4.7Blower | $19.8Bhigher |
| Earnings | $836.3Mlower | $993Mhigher |
| Employees | 11,000lower | 63,909higher |
| Total assets | $6.3Blower | $29.9Bhigher |
| Valuation | ||
| P/E | 32.3higher | 26.0lower |
| P/S | 6.6higher | 1.5lower |
| P/B | 12.1 | — |
| Dividend yield | 0.00% | — |
| Profitability | ||
| Operating margin | 19.6%higher | 7.98%lower |
| Balance sheet | ||
| Net assets | $2.7Blower | $12.2Bhigher |
| Total liabilities | $3.6Blower | $17.7Bhigher |
| Total debt | — | $9B |
| Cash on hand | $917.7Mlower | $3.1Bhigher |
| Price change | ||
| Today | +0.53%higher | -0.83%lower |
| 1 year | +35.6%higher | +9.64%lower |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (0)
None of the tracked investors.
DexCom only (2)
Koninklijke Philips only (4)
- Pat English1.2%
- Sarah Ketterer0.8%
- Charles Brandes (founder)0.4%
- Richard Pzena<0.1%
Percentages are each holding's share of that investor's reported portfolio. Who owns DXCM · Who owns PHG
More on DexCom
Further comparisons
DexCom against its closest peers
Koninklijke Philips against its closest peers
Learn
Questions and answers
Which is bigger, DexCom or Koninklijke Philips?
By market value, DexCom is the larger: $30.6B against $29.2B for Koninklijke Philips. By revenue in its latest fiscal year, Koninklijke Philips is the larger: $19.8B against $4.7B for DexCom.
Which has the higher P/E ratio?
DexCom: 32.3, against 26.0 for Koninklijke Philips. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher operating margin?
DexCom: 19.6%, against 7.98% for Koninklijke Philips. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which superinvestors own both DexCom and Koninklijke Philips?
None of the tracked superinvestors holds both in their latest 13F filing. 2 hold DexCom and 4 hold Koninklijke Philips.
Cite this page
Funkfolio, “DexCom vs Koninklijke Philips”, data as of 18 November 2026. https://funkfolio.com/compare/dxcm-vs-phg
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.